The sessions combine an artistic outlet with a place where breast cancer survivors and patients can share their experiences.

Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...

Olivia Munn has for more than a year been speaking out about the importance of a breast cancer risk assessment test that ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a ...

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast ...

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.

When offered the opportunity to participate in clinical trials, patients with breast cancer across racial and ethnic groups ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

NIH study could help to guide clinical recommendations for hormone therapy use among women under 55 years old.